English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Newly emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) pandemic has now spread across the globe in past few months while affecting 26 million people and leading to more than 0 85 million deaths as on 2nd September, 2020 Severity of SARS-CoV-2 infection increases in COVID-19 patients due to pre-existing health co-morbidities This mini-review has focused on the three significant co-morbidities viz , heart disease, hypertension, and diabetes, which are posing high health concerns and increased mortality during this ongoing pandemic The observed co-morbidities have been found to be associated with the increasing risk factors for SARS-CoV-2 infection and COVID-19 critical illness as well as to be associated positively with the worsening of the health condition of COVID-19 suffering individuals resulting in the high risk for mortality SARS-CoV-2 enters host cell via angiotensin-converting enzyme 2 receptors Regulation of crucial cardiovascular functions and metabolisms like blood pressure and sugar levels are being carried out by ACE2 This might be one of the reasons that contribute to the higher mortality in COVID-19 patients having co-morbidities Clinical investigations have identified higher levels of creatinine, cardiac troponin I, alanine aminotransferase, NT-proBNP, creatine kinase, D-dimer, aspartate aminotransferase and lactate dehydrogenase in patients who have succumbed to death from COVID-19 as compared to recovered individuals More investigations are required to identify the modes behind increased mortality in COVID-19 patients having co-morbidities of heart disease, hypertension, and diabetes This will enable us to design and develop suitable therapeutic strategies for reducing the mortality More attention and critical care need to be paid to such high risk patients suffering from co-morbidities during COVID-19 pandemic

COVID-19 and the World with Co-Morbidities of Heart Disease, Hypertension and Diabetes